Rhinocort

Budesonide on track for PBS Approval

Saturday, September 14th, 2013

Budesonide, a glucocorticoid steroid, is on the verge of being approved and listed by the PBS for treatment of ulcerative colitis. The approval process received a timely boost thanks to the PBAC recommendation in July’s meeting. Budesonide is to be recommended as an unrestricted benefit for treatment of rectosigmoid disease and active rectal disease in […]

Budenoside-Formoterol to Go Generic in 2014

Wednesday, September 4th, 2013

A combination drug with Budesonide (Rhinocort) and Formoterol is among a long list of medications that will be available in generic forms by 2014. The list includes other big name medications too, many of which will make things easier for people on Medicare with big savings on their medication costs. Many of these soon to […]

Rhinocort Useful in Treating Mild Asthma

Friday, August 23rd, 2013

Inhaled steroids like budesonide (brand name Rhinocort) could be useful in treating mild asthma. A recent study showed that this group of drugs is associated with less frequency of asthma attacks and more symptom-free days. There have been a few other studies to look for links between inhaled steroids and asthma, but their results have […]

Rhinocort Manufacturer Defends Patents at Federal Circuit

Monday, August 19th, 2013

AstraZeneca PLC filed a request at the Federal Circuit to stop four generic drug manufacturers from launching generic versions of its pediatric asthma medication, Pulmicort. The company said that a lower court relied too heavily on expert testimony to find that its patent on the drug was obvious and anticipated. Christopher N. Sipes, the attorney […]

Combination Treatment with Rhinocort for COPD could Lower Pneumonia Rate

Saturday, August 3rd, 2013

A meta-analysis of the large-scale PATHOS study shows that a combination of budenoside (brand name Rhinocort) and formoterol for Chronic Obstructive Pulmonary Disease (COPD) could lower the incidence risk of pneumonia. The study compared this combination with dual therapy with fluticasone and salmeterol. PATHOS is currently the largest real world study that compared the effectiveness […]

Rhinocort and Other Inhaled Steroids for Mild Asthma Treatment

Thursday, July 4th, 2013

Rhinocort (generic name budesonide) and other inhaled steroids could help reduce the frequency of asthma attacks and increase the number of symptom-free days for patients diagnosed with mild asthma, according to a recent study. Previous studies on the effect of inhaled steroids on mild asthma have returned inconclusive results. This latest study was done by […]

Foam form of Rhinocort Nearing Completion

Wednesday, June 12th, 2013

Salix Pharmaceuticals has recently announced positive results from two late-stage studies with budesonide foam for treating mild to moderate cases of active ulcerative proctitis or proctosigmoiditis (UP or UPS). Budesonide is also the generic name for rhinocort, the nasal spray indicated for treatment of asthma, rhinitis, and other breathing conditions. The two studies were double-blind, […]